SOLTF
Price:
$6.185
Market Cap:
$91.27B
Nxera Pharma Co., Ltd. is a biopharmaceutical enterprise specializing in the development and global commercialization of pharmaceutical products. Operating across Japan, Switzerland, the United States, Bermuda, and the United Kingdom, the company provides a range of established treatments. Its current commercialized offerings include Ultibro/Breezhaler and Seebri/Breezhaler, both prescribed for chronic obstructive pulmonary disease, as well as Enerzair and Breezhaler, which are utilized in asthma management. Additionally, the portfolio features ORAVI, an innovative formulation for treating oropharyngeal candidiasis, and PIVLAZ, indicated for cerebral vasospasm. Looking to the future, Nxera P...[Read more]
Industry
Biotechnology
IPO Date
2013-09-04
Stock Exchange
OTC
Ticker
SOLTF
According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 135.51B. This represents a change of 14.78% compared to the average of 118.05B of the last 4 quarters.
The mean historical Enterprise Value of Nxera Pharma Co., Ltd. over the last ten years is 127.99B. The current 135.51B Enterprise Value has changed 10.49% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's Enterprise Value was at its highest in in the June 2016 quarter at 306.48B. The Enterprise Value was at its lowest in in the December 2018 quarter at 49.17B.
Average
127.99B
Median
133.58B
Minimum
49.13B
Maximum
176.80B
Discovering the peaks and valleys of Nxera Pharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 211.10%
Maximum Annual Enterprise Value = 176.80B
Minimum Annual Increase = -64.26%
Minimum Annual Enterprise Value = 49.13B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 111.67B | -13.88% |
| 2024 | 129.67B | -8.79% |
| 2023 | 142.16B | 2.99% |
| 2022 | 138.03B | 11.53% |
| 2021 | 123.76B | 4.58% |
| 2020 | 118.34B | -22.58% |
| 2019 | 152.85B | 211.10% |
| 2018 | 49.13B | -64.26% |
| 2018 | 137.49B | -22.24% |
| 2017 | 176.80B | -28.46% |
The current Enterprise Value of Nxera Pharma Co., Ltd. (SOLTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
127.84B
5-year avg
129.06B
10-year avg
127.99B
Nxera Pharma Co., Ltd.’s Enterprise Value is greater than GenSight Biologics S.A. (23.81M), greater than Basilea Pharmaceutica AG (669.74M), greater than Viva Biotech Holdings (2.33B), greater than MedinCell S.A. (1.04B), greater than 4DMedical Limited (2.18B), greater than BioInvent International AB (publ) (1.16B), greater than Race Oncology Limited (454.27M), greater than Avacta Group Plc (330.19M), greater than ManifestSeven Holdings Corporation (22.25M), greater than JCR Pharmaceuticals Co., Ltd. (96.98B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 23.81M | $30.99M | |
| 669.74M | $746.00M | |
| 2.33B | $284.79M | |
| 1.04B | $1.23B | |
| 2.18B | $1.59B | |
| 1.16B | $216.40M | |
| 454.27M | $451.73M | |
| 330.19M | $454.97M | |
| 22.25M | $1.71K | |
| 96.98B | $383.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nxera Pharma Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 3-year average Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 5-year average Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF)?
How does the current Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF) compare to its historical average?